Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

41.71
-0.8200-1.93%
Post-market: 41.880.1700+0.41%19:59 EDT
Volume:11.67M
Turnover:489.94M
Market Cap:186.24B
PE:10.42
High:42.72
Open:42.47
Low:41.47
Close:42.53
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.39
T/O Rate:0.37%
Dividend:1.72
Dividend Rate:4.13%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.72
PE(LYR):11.52

Loading ...

How Novo Nordisk's CEO Says He is Shifting the Company's Perspective

Dow Jones
·
Aug 06

Movement Alert|Novo-Nordisk A/S Rises 3.12% in Pre-Market Trading, Post-Earnings Rebound Aided by Dutch Patent Injunction Win

Market Focus
·
Aug 06

Novo Nordisk's Conservative Guidance Leaves Room for Further Upgrades

Dow Jones
·
Aug 06

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.6%

TIPRANKS
·
Aug 06

Novo Nordisk (NYSE:NVO) Stock May Be Below Fair Value On ZEUS Trial Fallout

Simply Wall St.
·
Aug 06

European Stocks Stalled Near Records as HSBC and Novo Nordisk Weigh

Deep News
·
Aug 06

Money Quote: Novo Nordisk CEO

Dow Jones
·
Aug 06

How Ozempic Maker Novo Nordisk Blew Its Lead in GLP-1 Weight-Loss Drugs. Can Europe Compete in the High-Stakes Global Economy?

Dow Jones
·
Aug 06

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Aug 06

Novo Nordisk Stock (NVO) Recovers as Earnings Surprise to the Upside

TIPRANKS
·
Aug 05

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

Novo Nordisk Wins Dutch Injunction in Ceban Semaglutide Patent Case

MT Newswires Live
·
Aug 05

Movement Alert|Novo-Nordisk A/S Rises 3.11% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Aug 05

Novo Nordisk CEO Remains Open to Bolt-on Acquisitions, but Rules Out Transformative Deals

Dow Jones
·
Aug 05

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth

Bloomberg
·
Aug 05

UBS Keeps Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
Aug 05

Novo-Nordisk CEO Defends Wegovy Oral Pill Amid Pricing Pressure, Shares Slide on Sales Concern

Deep News
·
Aug 05

Movement Alert|Novo-Nordisk A/S Pre-Market Rise 5.04%, Q2 Earnings Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Aug 05

European Stocks Extend Record Highs

Dow Jones
·
Aug 05

Movement Alert|Novo-Nordisk A/S Rises 3.14% Overnight, Q2 Earnings Beat Expectations as Management Signals Confidence in GLP-1 Growth

Market Focus
·
Aug 05